Life ScienceCompany
Kimberly-Clark - Sofusa Lymphatic Delivery Platform Ownership
Who owns Kimberly-Clark - Sofusa Lymphatic Delivery Platform?
Kimberly-Clark - Sofusa Lymphatic Delivery Platform is owned by Sorrento Therapeutics. It was acquired on July 3, 2018.
Kimberly-Clark - Sofusa Lymphatic Delivery Platform Business Overview
Where is Kimberly-Clark - Sofusa Lymphatic Delivery Platform headquartered?
Kimberly-Clark - Sofusa Lymphatic Delivery Platform is headquartered in Dallas, Texas.
What sector is Kimberly-Clark - Sofusa Lymphatic Delivery Platform in?
Kimberly-Clark - Sofusa Lymphatic Delivery Platform is a life science company.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.